|
|
Applications of probability and statistics in cancer genomics |
Xiaotu Ma( ), Sasi Arunachalam, Yanling Liu |
Department of Computational Biology, and Cancer Biology Program, Comprehensive Cancer Center, St Jude Children’s Research Hospital, Memphis, TN 38105, USA |
|
|
Abstract Background: The past decade has witnessed a rapid progress in our understanding of the genetics of cancer and its progression. Probabilistic and statistical modeling played a pivotal role in the discovery of general patterns from cancer genomics datasets and continue to be of central importance for personalized medicine. Results: In this review we introduce cancer genomics from a probabilistic and statistical perspective. We start from (1) functional classification of genes into oncogenes and tumor suppressor genes, then (2) demonstrate the importance of comprehensive analysis of different mutation types for individual cancer genomes, followed by (3) tumor purity analysis, which in turn leads to (4) the concept of ploidy and clonality, that is next connected to (5) tumor evolution under treatment pressure, which yields insights into cancer drug resistance. We also discuss future challenges including the non-coding genomic regions, integrative analysis of genomics and epigenomics, as well as early cancer detection. Conclusion: We believe probabilistic and statistical modeling will continue to play important roles for novel discoveries in the field of cancer genomics and personalized medicine.
|
Keywords
cancer genomics
sequence analysis
probability and statistics
|
Corresponding Author(s):
Xiaotu Ma
|
Online First Date: 29 April 2020
Issue Date: 13 July 2020
|
|
1 |
P. C. Nowell, (2007) Discovery of the Philadelphia chromosome: a personal perspective. J. Clin. Invest., 117, 2033–2035
https://doi.org/10.1172/JCI31771.
pmid: 17671636
|
2 |
P. H. D. Nowell, (1960) A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497
|
3 |
F. Sanger, and A. R. Coulson, (1975) A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J. Mol. Biol., 94, 441–448
https://doi.org/10.1016/0022-2836(75)90213-2.
pmid: 1100841
|
4 |
R. A. Weinberg, (1991) Tumor suppressor genes. Science, 254, 1138–1146
https://doi.org/10.1126/science.1659741.
pmid: 1659741
|
5 |
J. R. Downing, , R. K. Wilson, , J. Zhang, , E. R. Mardis, , C. H. Pui, , L. Ding, , T. J. Ley, and W. E. Evans, (2012) The Pediatric Cancer Genome Project. Nat. Genet., 44, 619–622
https://doi.org/10.1038/ng.2287.
pmid: 22641210
|
6 |
Cancer Genome Atlas Research Network. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061–1068
https://doi.org/10.1038/nature07385.
pmid: 18772890
|
7 |
X. Ma, , Y. Liu, , Y. Liu, , L. B. Alexandrov, , M. N. Edmonson, , C. Gawad, , X. Zhou, , Y. Li, , M. C. Rusch, , J. Easton, , et al. (2018) Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature, 555, 371–376
https://doi.org/10.1038/nature25795.
pmid: 29489755
|
8 |
S. N. Gröbner, , B. C. Worst, , J. Weischenfeldt, , I. Buchhalter, , K. Kleinheinz, , V. A. Rudneva, , P. D. Johann, , G. P. Balasubramanian, , M. Segura-Wang, , S. Brabetz, , et al. (2018) The landscape of genomic alterations across childhood cancers. Nature, 555, 321–327
https://doi.org/10.1038/nature25480.
pmid: 29489754
|
9 |
M. S. Lawrence, , P. Stojanov, , C. H. Mermel, , J. T. Robinson, , L. A. Garraway, , T. R. Golub, , M. Meyerson, , S. B. Gabriel, , E. S. Lander, and G. Getz, (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature, 505, 495–501
https://doi.org/10.1038/nature12912.
pmid: 24390350
|
10 |
K. A. Hoadley, , C. Yau, , D. M. Wolf, , A. D. Cherniack,, D. Tamborero, , S. Ng, , M. D. M. Leiserson,, B. Niu, , M. D. McLellan, , V. Uzunangelov,, et al. (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell, 158, 929–944
https://doi.org/10.1016/j.cell.2014.06.049.
pmid: 25109877
|
11 |
T. I. Zack, , S. E. Schumacher,, S. L. Carter, , A. D. Cherniack, , G. Saksena,, B. Tabak, , M. S. Lawrence, , C. Z. Zhang, , J. Wala, , C. H. Mermel, , et al. (2013) Pan-cancer patterns of somatic copy number alteration. Nat. Genet., 45, 1134–1140
https://doi.org/10.1038/ng.2760.
pmid: 24071852
|
12 |
M. Rusch, , J. Nakitandwe,, S. Shurtleff, , S. Newman, , Z. Zhang, , M. N. Edmonson, , M. Parker, , Y. Jiao, , X. Ma, , Y. Liu,, et al. (2018) Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. Nat. Commun., 9, 3962
https://doi.org/10.1038/s41467-018-06485-7.
pmid: 30262806
|
13 |
E. Crowley, , F. Di Nicolantonio,, F. Loupakis, and A. Bardelli, (2013) Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol., 10, 472–484
https://doi.org/10.1038/nrclinonc.2013.110.
pmid: 23836314
|
14 |
J. D. Cohen, , L. Li, , Y. Wang, , C. Thoburn,, B. Afsari, , L. Danilova, , C. Douville, , A. A. Javed, , F. Wong, , A. Mattox, , et al. (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science, 359, 926–930
https://doi.org/10.1126/science.aar3247.
pmid: 29348365
|
15 |
C. Tomasetti, , B. Vogelstein, and G. Parmigiani, (2013) Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl. Acad. Sci. USA, 110, 1999–2004
https://doi.org/10.1073/pnas.1221068110.
pmid: 23345422
|
16 |
T. A. Kunkel, and D. A. Erie, (2015) Eukaryotic mismatch repair in relation to DNA replication. Annu. Rev. Genet., 49, 291–313
https://doi.org/10.1146/annurev-genet-112414-054722.
pmid: 26436461
|
17 |
L. A. Forsberg, , D. Gisselsson, and J. P. Dumanski, (2017) Mosaicism in health and disease—clones picking up speed. Nat. Rev. Genet., 18, 128–142
https://doi.org/10.1038/nrg.2016.145.
pmid: 27941868
|
18 |
E. Bianconi, , A. Piovesan, , F. Facchin, , A. Beraudi, , R. Casadei, , F. Frabetti, , L. Vitale, , M. C. Pelleri, , S. Tassani, , F. Piva, , et al. (2013) An estimation of the number of cells in the human body. Ann. Hum. Biol., 40, 463–471
https://doi.org/10.3109/03014460.2013.807878.
pmid: 23829164
|
19 |
C. M. Testa, and J. Jankovic, (2019) Huntington disease: A quarter century of progress since the gene discovery. J. Neurol. Sci., 396, 52–68
https://doi.org/10.1016/j.jns.2018.09.022.
pmid: 30419368
|
20 |
J. Zhang, , M. F. Walsh, , G. Wu, , M. N. Edmonson, , T. A. Gruber, , J. Easton, , D. Hedges, , X. Ma, , X. Zhou, , D. A. Yergeau,, et al. (2015) Germline mutations in predisposition genes in pediatric cancer. N. Engl. J. Med., 373, 2336–2346
https://doi.org/10.1056/NEJMoa1508054.
pmid: 26580448
|
21 |
B. Vogelstein, , N. Papadopoulos,, V. E. Velculescu, , S. Zhou, , L. A. Diaz, Jr and K. W. Kinzler, (2013) Cancer genome landscapes. Science, 339, 1546–1558
https://doi.org/10.1126/science.1235122.
pmid: 23539594
|
22 |
S. Pounds, , C. Cheng, , S. Li, , Z. Liu, , J. Zhang, and C. Mullighan, (2013) A genomic random interval model for statistical analysis of genomic lesion data. Bioinformatics, 29, 2088–2095
https://doi.org/10.1093/bioinformatics/btt372.
pmid: 23842812
|
23 |
M. S. Lawrence, , P. Stojanov, , P. Polak, , G. V. Kryukov, , K. Cibulskis,, A. Sivachenko, , S. L. Carter, , C. Stewart, , C. H. Mermel, , S. A. Roberts, , et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 499, 214–218
https://doi.org/10.1038/nature12213.
pmid: 23770567
|
24 |
N. D. Dees, , Q. Zhang, , C. Kandoth, , M. C. Wendl, , W. Schierding,, D. C. Koboldt, , T. B. Mooney, , M. B. Callaway, , D. Dooling, , E. R. Mardis, , et al. (2012) MuSiC: identifying mutational significance in cancer genomes. Genome Res., 22, 1589–1598
https://doi.org/10.1101/gr.134635.111.
pmid: 22759861
|
25 |
T. Soussi, and K. G. Wiman, (2015) TP53: an oncogene in disguise. Cell Death Differ., 22, 1239–1249
https://doi.org/10.1038/cdd.2015.53.
pmid: 26024390
|
26 |
International Human Genome Sequencing Consortium. (2004) Finishing the euchromatic sequence of the human genome. Nature, 431, 931–945
https://doi.org/10.1038/nature03001.
pmid: 15496913
|
27 |
Cancer Genome Atlas Research Network. (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature, 489, 519–525
https://doi.org/10.1038/nature11404.
pmid: 22960745
|
28 |
M. S. Lawrence, , P. Stojanov, , P. Polak, , G. V. Kryukov, , K. Cibulskis,, A. Sivachenko, , S. L. Carter, , C. Stewart, , C. H. Mermel, , S. A. Roberts, , et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 499, 214–218
https://doi.org/10.1038/nature12213.
pmid: 23770567
|
29 |
X. Ma, , M. Edmonson, , D. Yergeau, , D. M. Muzny, , O. A. Hampton, , M. Rusch, , G. Song, , J. Easton, , R. C. Harvey, , D. A. Wheeler, , et al. (2015) Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat. Commun., 6, 6604
https://doi.org/10.1038/ncomms7604.
pmid: 25790293
|
30 |
S. Nik-Zainal, , L. B. Alexandrov,, D. C. Wedge, , P. Van Loo, , C. D. Greenman, , K. Raine, , D. Jones, , J. Hinton, , J. Marshall, , L. A. Stebbings, , et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell, 149, 979–993
https://doi.org/10.1016/j.cell.2012.04.024.
pmid: 22608084
|
31 |
S. T. Sherry, , M. H. Ward, , M. Kholodov, , J. Baker, , L. Phan, , E. M. Smigielski, and K. Sirotkin, (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res., 29, 308–311
https://doi.org/10.1093/nar/29.1.308.
pmid: 11125122
|
32 |
M. Griffith, , C. A. Miller, , O. L. Griffith, , K. Krysiak, , Z. L. Skidmore, , A. Ramu, , J. R. Walker, , H. X. Dang, , L. Trani, , D. E. Larson,, et al. (2015) Optimizing cancer genome sequencing and analysis. Cell Syst., 1, 210–223
https://doi.org/10.1016/j.cels.2015.08.015.
pmid: 26645048
|
33 |
K. E. Sundling, and A. C. Lowe, (2019) Circulating tumor cells: overview and opportunities in cytology. Adv. Anat. Pathol., 26, 56–63
https://doi.org/10.1097/PAP.0000000000000217.
pmid: 30325755
|
34 |
P. M. Kakadia, , N. Van de Water,, P. J. Browett, and S. K. Bohlander, (2018) Efficient identification of somatic mutations in acute myeloid leukaemia using whole exome sequencing of fingernail derived DNA as germline control. Sci. Rep., 8, 13751
https://doi.org/10.1038/s41598-018-31503-5.
pmid: 30213991
|
35 |
K. Mrózek, , N. A. Heerema, and C. D. Bloomfield, (2004) Cytogenetics in acute leukemia. Blood Rev., 18, 115–136
https://doi.org/10.1016/S0268-960X(03)00040-7.
pmid: 15010150
|
36 |
D. W. Craig, , S. Nasser, , R. Corbett, , S. K. Chan, , L. Murray, , C. Legendre, , W. Tembe, , J. Adkins, , N. Kim, , S. Wong, , et al. (2016) A somatic reference standard for cancer genome sequencing. Sci. Rep., 6, 24607
https://doi.org/10.1038/srep24607.
pmid: 27094764
|
37 |
B. Li, , S. W. Brady, , X. Ma, , S. Shen, , Y. Zhang, , Y. Li, , K. Szlachta, , L. Dong, , Y. Liu, , F. Yang,, et al. (2019) Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood, 135, 41–55
pmid: 31697823.
|
38 |
S. W. Brady, , X. Ma, , A. Bahrami, , G. Satas,, G. Wu, , S. Newman, , M. Rusch, , D. K. Putnam, , H. L. Mulder, , D. A. Yergeau, , et al. (2019) The clonal evolution of metastatic osteosarcoma as shaped by cisplatin treatment. Mol. Cancer Res., 17, 895–906
https://doi.org/10.1158/1541-7786.MCR-18-0620.
pmid: 30651371
|
39 |
B. Li, , H. Li, , Y. Bai, , R. Kirschner-Schwabe,, J. J. Yang, , Y. Chen, , G. Lu, , G. Tzoneva, , X. Ma,, T. Wu, , et al. (2015) Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL. Nat. Med., 21, 563–571
https://doi.org/10.1038/nm.3840.
pmid: 25962120
|
40 |
J. J. Salk, , M. W. Schmitt, and L. A. Loeb, (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat. Rev. Genet., 19, 269–285
https://doi.org/10.1038/nrg.2017.117.
pmid: 29576615
|
41 |
S. Goodwin, , J. D. McPherson, and W. R. McCombie, (2016) Coming of age: ten years of next-generation sequencing technologies. Nat. Rev. Genet., 17, 333–351
https://doi.org/10.1038/nrg.2016.49.
pmid: 27184599
|
42 |
E. R. Mardis, (2013) Next-generation sequencing platforms. Annu. Rev. Anal. Chem. (Palo Alto, Calif.), 6, 287–303
https://doi.org/10.1146/annurev-anchem-062012-092628.
pmid: 23560931
|
43 |
T. C. Glenn, (2011) Field guide to next-generation DNA sequencers. Mol. Ecol. Resour., 11, 759–769
https://doi.org/10.1111/j.1755-0998.2011.03024.x.
pmid: 21592312
|
44 |
D. T. Cheng, , T. N. Mitchell, , A. Zehir, , R. H. Shah, , R. Benayed, , A. Syed, , R. Chandramohan, , Z. Y. Liu,, H. H. Won, , S. N. Scott, , et al. (2015) Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn., 17, 251–264
https://doi.org/10.1016/j.jmoldx.2014.12.006.
pmid: 25801821
|
45 |
X. Ma, , Y. Shao, , L. Tian, , D. A. Flasch,, H. L. Mulder, , M. N. Edmonson, , Y. Liu, , X. Chen, , S. Newman,, J. Nakitandwe, , et al. (2019) Analysis of error profiles in deep next-generation sequencing data. Genome Biol., 20, 50
https://doi.org/10.1186/s13059-019-1659-6.
pmid: 30867008
|
46 |
A. L. Young, , G. A. Challen, , B. M. Birmann, and T. E. Druley, (2016) Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat. Commun., 7, 12484
https://doi.org/10.1038/ncomms12484.
pmid: 27546487
|
47 |
P. Ulz, , E. Heitzer, , J. B. Geigl, and M. R. Speicher, (2017) Patient monitoring through liquid biopsies using circulating tumor DNA. Int. J. Cancer, 141, 887–896
https://doi.org/10.1002/ijc.30759.
pmid: 28470712
|
48 |
M. E. Figueroa, , S. Lugthart, , Y. Li, , C. Erpelinck-Verschueren, , X. Deng, , P. J. Christos, , E. Schifano, , J. Booth, , W. van Putten,, L. Skrabanek, , et al. (2010) DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell, 17, 13–27
https://doi.org/10.1016/j.ccr.2009.11.020.
pmid: 20060365
|
49 |
X. Ma, , Y. W. Wang, , M. Q. Zhang, and A. F. Gazdar, (2013) DNA methylation data analysis and its application to cancer research. Epigenomics, 5, 301–316
https://doi.org/10.2217/epi.13.26.
pmid: 23750645
|
50 |
M. Zeineldin,, S. Federico,, X. Chen,, B. Xu,, E. Stewart,, A. Naranjo,, M.D. Hogarty,, M.A Dyer,. (2020) MYCN amplification and ATRX mutations are incompatible in neuroblastoma. Nat. Commun., 11, 913
|
51 |
I. Iacobucci, , Y. Li, , K. G. Roberts, , S. M. Dobson, , J. C. Kim, , D. Payne-Turner, , R. C. Harvey, , M. Valentine,, K. McCastlain, , J. Easton, , et al. (2016) Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia. Cancer Cell, 29, 186–200
https://doi.org/10.1016/j.ccell.2015.12.013.
pmid: 26859458
|
52 |
J. Zhang, , K. McCastlain,, H. Yoshihara, , B. Xu, , Y. Chang, , M. L. Churchman, , G. Wu, , Y. Li, , L. Wei, , I. Iacobucci,, et al. (2016) Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat. Genet., 48, 1481–1489
https://doi.org/10.1038/ng.3691.
pmid: 27776115
|
53 |
M. R. Mansour, , B. J. Abraham, , L. Anders, , A. Berezovskaya, , A. Gutierrez,, A. D. Durbin, , J. Etchin, , L. Lawton, , S. E. Sallan, , L. B. Silverman, , et al. (2014) Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science, 346, 1373–1377
https://doi.org/10.1126/science.1259037.
pmid: 25394790
|
54 |
F. W. Huang, , E. Hodis, , M. J. Xu, , G. V. Kryukov, , L. Chin, and L. A. Garraway, (2013) Highly recurrent TERT promoter mutations in human melanoma. Science, 339, 957–959
https://doi.org/10.1126/science.1229259.
pmid: 23348506
|
55 |
H. Zhang, , X. Si, , X. Ji, , R. Fan,, J. Liu, , K. Chen, , D. Wang, and C. Gao, (2018) Genome editing of upstream open reading frames enables translational control in plants. Nat. Biotechnol., 36, 894–898
https://doi.org/10.1038/nbt.4202.
pmid: 30080209
|
56 |
L. B. Alexandrov, , S. Nik-Zainal,, D. C. Wedge, , P. J. Campbell, and M. R. Stratton, (2013) Deciphering signatures of mutational processes operative in human cancer. Cell Reports, 3, 246–259
https://doi.org/10.1016/j.celrep.2012.12.008.
pmid: 23318258
|
57 |
L. B. Alexandrov, , S. Nik-Zainal,, D. C. Wedge, , S. A. Aparicio, , S. Behjati, , A. V. Biankin, , G. R. Bignell, , N. Bolli, , A. Borg, , A. L. Børresen-Dale, , et al. (2013) Signatures of mutational processes in human cancer. Nature, 500, 415–421
https://doi.org/10.1038/nature12477.
pmid: 23945592
|
58 |
A. W. T. Ng, , S. L. Poon, , M. N. Huang, , J. Q. Lim, , A. Boot, , W. Yu, , Y. Suzuki,, S. Thangaraju, , C. C. Y. Ng, , P. Tan, , et al. (2017) Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci. Transl. Med., 9, eaan6446
https://doi.org/10.1126/scitranslmed.aan6446.
pmid: 29046434
|
59 |
D. E. Brash, (2015) UV signature mutations. Photochem. Photobiol., 91, 15–26
https://doi.org/10.1111/php.12377.
pmid: 25354245
|
60 |
M. Petljak,, L.B. Alexandrov,, J.S. Brammeld,, S. Price,, D.C. Wedge,, S. Grossmann,, K.J. Dawson,, Y.S. Ju,, F. Iorio,, J.M.C. Tubio,, et al. (2019) Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis. Cell, 176, 1282–1294
|
61 |
K. Ye, , J. Wang, , R. Jayasinghe, , E. W. Lameijer, , J. F. McMichael,, J. Ning, , M. D. McLellan, , M. Xie, , S. Cao, , V. Yellapantula,, et al. (2016) Systematic discovery of complex insertions and deletions in human cancers. Nat. Med., 22, 97–104
https://doi.org/10.1038/nm.4002.
pmid: 26657142
|
62 |
J. L. Wiemels, , B. C. Leonard, , Y. Wang, , M. R. Segal, , S. P. Hunger, , M. T. Smith, , V. Crouse, , X. Ma, , P. A. Buffler, and S. R. Pine, (2002) Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA, 99, 15101–15106
https://doi.org/10.1073/pnas.222481199.
pmid: 12415113
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|